| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01HX006 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01HX006 (ip) | mean survival time | saline | 90.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01HX006 (ip) | mean survival time | saline | 120.0 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX032 (ip) | mean survival time | alkali diluted with saline | 4.4 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX032 (ip) | mean survival time | alkali diluted with saline | 4.4 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX032 (ip) | mean survival time | alkali diluted with saline | 6.7 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX032 (ip) | mean survival time | alkali diluted with saline | 6.7 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX032 (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX032 (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX032 (ip) | mean survival time | alkali diluted with saline | 15.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX032 (ip) | mean survival time | alkali diluted with saline | 15.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX032 (ip) | mean survival time | alkali diluted with saline | 22.5 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX032 (ip) | mean survival time | alkali diluted with saline | 22.5 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q06HX012 (ip) | mean survival time | alkali diluted with saline | 13.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q06HX012 (ip) | mean survival time | alkali diluted with saline | 20.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q06HX012 (ip) | mean survival time | alkali diluted with saline | 30.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q06HX012 (ip) | mean survival time | alkali diluted with saline | 45.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX006 (ip) | mean survival time | alkali diluted with saline | 30.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX006 (ip) | mean survival time | alkali diluted with saline | 45.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX006 (ip) | mean survival time | alkali diluted with saline | 67.5 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX006 (ip) | mean survival time | alkali diluted with saline | 100.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX006 (ip) | mean survival time | alkali diluted with saline | 150.0 mg/kg/injection | 189.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX012 (ip) | mean survival time | alkali diluted with saline | 3.5 mg/kg/injection | 124.0 | Antitumor endpoint evaluated on day 5; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q12HX012 (ip) | mean survival time | alkali diluted with saline | 5.3 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX012 (ip) | mean survival time | alkali diluted with saline | 8.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX012 (ip) | mean survival time | alkali diluted with saline | 13.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX012 (ip) | mean survival time | alkali diluted with saline | 20.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX012 (ip) | mean survival time | alkali diluted with saline | 30.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX012 (ip) | mean survival time | alkali diluted with saline | 45.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX012 (ip) | mean survival time | alkali diluted with saline | 67.5 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q12HX012 (ip) | mean survival time | alkali diluted with saline | 100.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 36.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 60.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 100.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 167.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 90.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 35; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 120.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 120.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 120.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 120.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 120.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 120.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 120.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 120.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 180.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | saline | 270.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 250.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 500.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 1000.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 2.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 4.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 8.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 16.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 32.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 40.0 mg/kg/injection | 134.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 40.0 mg/kg/injection | 136.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 59.0 mg/kg/injection | 137.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 60.0 mg/kg/injection | 137.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 64.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 90.0 mg/kg/injection | 150.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 90.0 mg/kg/injection | 151.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 128.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 135.0 mg/kg/injection | 141.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 135.0 mg/kg/injection | 154.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 150.0 mg/kg/injection | 156.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 203.0 mg/kg/injection | 122.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 256.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | carboxymethylcellulose (CMC) | 512.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 0.15 mg/kg/injection | 102.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 0.3 mg/kg/injection | 101.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 0.6 mg/kg/injection | 101.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 0.6 mg/kg/injection | 93.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 1.1 mg/kg/injection | 104.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 1.3 mg/kg/injection | 101.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 2.2 mg/kg/injection | 104.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 4.4 mg/kg/injection | 137.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 4.4 mg/kg/injection | 102.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 8.8 mg/kg/injection | 163.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 17.5 mg/kg/injection | 174.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 35.0 mg/kg/injection | 183.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 35.0 mg/kg/injection | 137.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 70.0 mg/kg/injection | 127.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 70.0 mg/kg/injection | 140.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 70.0 mg/kg/injection | 177.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 70.0 mg/kg/injection | 165.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 140.0 mg/kg/injection | 118.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 140.0 mg/kg/injection | 162.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 280.0 mg/kg/injection | 127.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 280.0 mg/kg/injection | 154.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 560.0 mg/kg/injection | 138.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 560.0 mg/kg/injection | 139.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 560.0 mg/kg/injection | 118.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | other | 1020.0 mg/kg/injection | 148.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | steriod suspending solution | 50.0 mg/kg/injection | 137.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | steriod suspending solution | 100.0 mg/kg/injection | 152.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | steriod suspending solution | 200.0 mg/kg/injection | 147.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | steriod suspending solution | 400.0 mg/kg/injection | 137.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 104.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 111.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 117.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 118.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 109.0 mg/kg/injection | 112.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 109.0 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 134.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 131.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 146.0 mg/kg/injection | 108.0 | Experiment continued until the death of all animals; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 146.0 mg/kg/injection | 112.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 200.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 46; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 200.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 202.0 mg/kg/injection | 142.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 300.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 46; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 300.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 400.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 46; 08/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 400.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 46; 08/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 500.0 mg/kg/injection | 211.0 | Antitumor endpoint evaluated on day 46; 06/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 500.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 46; 05/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 600.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 46; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean survival time | alkali diluted with saline | 600.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 46; 02/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 263.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 90.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 90.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 90.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 90.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 180.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 180.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 180.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | saline | 180.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 114.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 114.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 20.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 40.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 80.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 93.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 30; 04/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 102.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | other | 160.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 02/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 120.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 150.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 180.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 20.0 mg/kg/injection | 111.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 20.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 20.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 40.0 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 40.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 40.0 mg/kg/injection | 124.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 80.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 80.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 80.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 160.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 160.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 160.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX006 (iv) | mean survival time | other | 10.0 mg/kg/injection | 103.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX006 (iv) | mean survival time | other | 20.0 mg/kg/injection | 108.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX006 (iv) | mean survival time | other | 40.0 mg/kg/injection | 111.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX006 (iv) | mean survival time | other | 80.0 mg/kg/injection | 121.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX006 (iv) | mean survival time | other | 80.0 mg/kg/injection | 146.0 | Experiment continued until the death of all animals; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX006 (iv) | mean survival time | other | 160.0 mg/kg/injection | 151.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX006 (iv) | mean survival time | other | 320.0 mg/kg/injection | 157.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX006 (iv) | mean survival time | other | 320.0 mg/kg/injection | 130.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX006 (iv) | mean survival time | other | 640.0 mg/kg/injection | 112.0 | Experiment continued until the death of all animals; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX006 (iv) | mean survival time | other | 960.0 mg/kg/injection | 112.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 100.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 160.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 160.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 160.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | water | 25.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | water | 50.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | water | 100.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | water | 200.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 6.25 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 12.5 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 25.0 mg/kg/injection | 111.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 25.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 50.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 50.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 100.0 mg/kg/injection | 111.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 100.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 07/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline | 7.5 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline | 12.5 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline | 25.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline | 50.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline | 90.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 25.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 50.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 62.5 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 100.0 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 125.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 200.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 250.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 400.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 800.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 10.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 10.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 20.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 20.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 40.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 40.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 80.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 80.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 135.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 160.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 160.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 205.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 305.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 320.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 320.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 640.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 04/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | saline with Tween-80 | 640.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | carboxymethylcellulose (CMC) | 15.0 mg/kg/injection | 192.0 | Antitumor endpoint evaluated on day 60; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | carboxymethylcellulose (CMC) | 30.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 60; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | carboxymethylcellulose (CMC) | 45.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 60; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | carboxymethylcellulose (CMC) | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 60; 08/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | carboxymethylcellulose (CMC) | 60.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | carboxymethylcellulose (CMC) | 90.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | carboxymethylcellulose (CMC) | 120.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | carboxymethylcellulose (CMC) | 240.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 15.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 15.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 30.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 30.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 39.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 45.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 60.0 mg/kg/injection | 334.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 60.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 60; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 60.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 65.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 90.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 108.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 120.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 120.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 180.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 240.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | other | 240.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 60; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 1.9 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 1.9 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 3.8 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 3.8 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 7.5 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 7.5 mg/kg/injection | 114.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 15.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 15.0 mg/kg/injection | 124.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 15.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 15.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 15.0 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 18.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 27.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 27.0 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 29.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 29.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 29.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 29.0 mg/kg/injection | 124.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 30.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 45.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 57.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 57.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 57.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 57.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 204.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 236.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 114.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 02/02 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 114.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 120.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 200.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 202.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 240.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | acetone | 11.25 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | acetone | 22.5 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | acetone | 45.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | mean survival time | acetone | 90.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 10.0 mg/kg/injection | 102.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 10.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 20.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 20.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 40.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 40.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 80.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 80.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 160.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 160.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 320.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 320.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 640.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | mean survival time | saline with Tween-80 | 640.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 5.0 mg/kg/injection | 101.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 5.0 mg/kg/injection | 100.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 5.0 mg/kg/injection | 96.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 5.0 mg/kg/injection | 97.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 102.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 94.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 105.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 108.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 20.0 mg/kg/injection | 98.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 20.0 mg/kg/injection | 108.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 20.0 mg/kg/injection | 108.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 20.0 mg/kg/injection | 101.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 120.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 131.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 113.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 128.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 80.0 mg/kg/injection | 146.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 80.0 mg/kg/injection | 148.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 80.0 mg/kg/injection | 128.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean survival time | alkali diluted with saline | 80.0 mg/kg/injection | 157.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean survival time | alkali diluted with saline | 35.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean survival time | alkali diluted with saline | 35.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean survival time | alkali diluted with saline | 53.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean survival time | alkali diluted with saline | 53.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean survival time | alkali diluted with saline | 80.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean survival time | alkali diluted with saline | 80.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean survival time | alkali diluted with saline | 120.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean survival time | alkali diluted with saline | 120.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX014 (ip) | mean survival time | alkali diluted with saline | 30.0 mg/kg/injection | 143.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX014 (ip) | mean survival time | alkali diluted with saline | 30.0 mg/kg/injection | 138.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX014 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 137.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX014 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 144.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX014 (ip) | mean survival time | alkali diluted with saline | 120.0 mg/kg/injection | 0.0 | Experiment continued until the death of all animals; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX014 (ip) | mean survival time | alkali diluted with saline | 120.0 mg/kg/injection | 0.0 | Experiment continued until the death of all animals; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | saline | 90.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | saline | 180.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | carboxymethylcellulose (CMC) | 8.0 mg/kg/injection | 136.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | carboxymethylcellulose (CMC) | 9.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | carboxymethylcellulose (CMC) | 12.0 mg/kg/injection | 169.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | carboxymethylcellulose (CMC) | 13.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | carboxymethylcellulose (CMC) | 16.0 mg/kg/injection | 149.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | carboxymethylcellulose (CMC) | 20.0 mg/kg/injection | 150.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | carboxymethylcellulose (CMC) | 20.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | carboxymethylcellulose (CMC) | 24.0 mg/kg/injection | 156.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | carboxymethylcellulose (CMC) | 30.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | carboxymethylcellulose (CMC) | 45.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 3.25 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 6.3 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 7.5 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 11.3 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 15.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 17.5 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 25.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 30.0 mg/kg/injection | 116.0 | Experiment continued until the death of all animals; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 30.0 mg/kg/injection | 138.0 | Experiment continued until the death of all animals; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 30.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 37.5 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 45.0 mg/kg/injection | 142.0 | Experiment continued until the death of all animals; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 45.0 mg/kg/injection | 144.0 | Experiment continued until the death of all animals; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 56.3 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 67.0 mg/kg/injection | 146.0 | Experiment continued until the death of all animals; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 67.0 mg/kg/injection | 125.0 | Experiment continued until the death of all animals; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 101.0 mg/kg/injection | 143.0 | Experiment continued until the death of all animals; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 101.0 mg/kg/injection | 114.0 | Experiment continued until the death of all animals; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 151.0 mg/kg/injection | 105.0 | Experiment continued until the death of all animals; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | other | 151.0 mg/kg/injection | 0.0 | Experiment continued until the death of all animals; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 0.63 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 1.25 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 2.5 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 5.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 6.0 mg/kg/injection | 116.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 6.25 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 6.25 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 6.25 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 6.25 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 9.0 mg/kg/injection | 127.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 12.5 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 12.5 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 12.5 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 12.5 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 14.0 mg/kg/injection | 124.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 18.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 22.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 22.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 25.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 25.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 25.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 25.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 27.0 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 27.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 29.0 mg/kg/injection | 124.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 30.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 33.5 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 33.5 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 44.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 65.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 70.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 75.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 75.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 75.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 5; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 45; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 5; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 98.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 100.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 112.5 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 112.5 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 125.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 146.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX015 (ip) | mean survival time | alkali diluted with saline | 150.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 46; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | median survival time | other | 12.5 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 54; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | median survival time | other | 25.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 54; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | median survival time | other | 50.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 54; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | median survival time | other | 100.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 54; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | mean survival time | other | 6.3 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 33; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | mean survival time | other | 12.5 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 33; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | mean survival time | other | 25.0 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 33; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | mean survival time | other | 50.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 33; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | mean survival time | other | 100.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 33; 07/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 2.0 mg/kg/injection | 113.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 3.5 mg/kg/injection | 147.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 3.5 mg/kg/injection | 132.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 3.5 mg/kg/injection | 128.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 3.5 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 3.5 mg/kg/injection | 123.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 3.5 mg/kg/injection | 111.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 3.5 mg/kg/injection | 115.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 3.5 mg/kg/injection | 127.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 5.0 mg/kg/injection | 134.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 5.0 mg/kg/injection | 117.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 147.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 140.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 135.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 134.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 141.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 135.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 144.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 151.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 134.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 8.56 mg/kg/injection | 138.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 10.0 mg/kg/injection | 151.0 | Experiment continued until the death of all animals; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 10.0 mg/kg/injection | 144.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 10.7 mg/kg/injection | 155.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 190.0 | Experiment continued until the death of all animals; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 156.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 163.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 156.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 137.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 153.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 172.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 178.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 147.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.26 mg/kg/injection | 163.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.26 mg/kg/injection | 165.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 20.0 mg/kg/injection | 173.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 20.0 mg/kg/injection | 174.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 21.4 mg/kg/injection | 158.0 | Experiment continued until the death of all animals; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 21.4 mg/kg/injection | 181.0 | Experiment continued until the death of all animals; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 141.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 195.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 183.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 181.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 166.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 149.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 162.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 177.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 136.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 28.52 mg/kg/injection | 173.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 35.65 mg/kg/injection | 151.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 40.0 mg/kg/injection | 174.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 40.0 mg/kg/injection | 120.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 40.0 mg/kg/injection | 145.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 56.0 mg/kg/injection | 122.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 56.0 mg/kg/injection | 160.0 | Experiment continued until the death of all animals; 05/05 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 56.0 mg/kg/injection | 151.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 56.0 mg/kg/injection | 125.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 80.0 mg/kg/injection | 112.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 80.0 mg/kg/injection | 105.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 80.0 mg/kg/injection | 113.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 160.0 mg/kg/injection | 0.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 320.0 mg/kg/injection | 0.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 1070.0 micrograms/kg/injection | 159.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 2140.0 micrograms/kg/injection | 159.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 2675.0 micrograms/kg/injection | 108.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | carboxymethylcellulose (CMC) | 5350.0 micrograms/kg/injection | 132.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 0.15 mg/kg/injection | 98.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 0.3 mg/kg/injection | 101.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 0.6 mg/kg/injection | 96.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 1.3 mg/kg/injection | 118.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 1.3 mg/kg/injection | 102.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 2.5 mg/kg/injection | 130.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 2.5 mg/kg/injection | 107.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 5.0 mg/kg/injection | 144.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 10.0 mg/kg/injection | 136.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 10.0 mg/kg/injection | 196.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 12.5 mg/kg/injection | 105.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 12.5 mg/kg/injection | 125.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 20.0 mg/kg/injection | 148.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 25.0 mg/kg/injection | 117.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 25.0 mg/kg/injection | 137.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 40.0 mg/kg/injection | 158.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 50.0 mg/kg/injection | 151.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 50.0 mg/kg/injection | 135.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 80.0 mg/kg/injection | 152.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 80.0 mg/kg/injection | 163.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 100.0 mg/kg/injection | 141.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 100.0 mg/kg/injection | 90.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 160.0 mg/kg/injection | 124.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 200.0 mg/kg/injection | 91.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 200.0 mg/kg/injection | 120.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | other | 320.0 mg/kg/injection | 0.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | alkali diluted with saline | 3.5 mg/kg/injection | 114.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | alkali diluted with saline | 5.0 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | alkali diluted with saline | 5.0 mg/kg/injection | 104.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | alkali diluted with saline | 7.0 mg/kg/injection | 122.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 127.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | alkali diluted with saline | 14.0 mg/kg/injection | 126.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | alkali diluted with saline | 20.0 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | alkali diluted with saline | 20.0 mg/kg/injection | 121.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (ip) | mean survival time | alkali diluted with saline | 28.0 mg/kg/injection | 114.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (sc) | mean survival time | other | 10.0 mg/kg/injection | 111.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (sc) | mean survival time | other | 20.0 mg/kg/injection | 136.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (sc) | mean survival time | other | 40.0 mg/kg/injection | 145.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (sc) | mean survival time | other | 80.0 mg/kg/injection | 142.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (sc) | mean survival time | other | 80.0 mg/kg/injection | 162.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (sc) | mean survival time | other | 160.0 mg/kg/injection | 121.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (sc) | mean survival time | other | 320.0 mg/kg/injection | 0.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 131.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 107.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 106.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 108.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 7.0 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 131.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 138.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 120.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 120.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 164.0 | Experiment continued until the death of all animals; 05/05 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 135.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 132.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 147.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 28.0 mg/kg/injection | 134.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 56.0 mg/kg/injection | 176.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 56.0 mg/kg/injection | 167.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 56.0 mg/kg/injection | 168.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 56.0 mg/kg/injection | 133.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | carboxymethylcellulose (CMC) | 56.0 mg/kg/injection | 151.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | other | 5.0 mg/kg/injection | 124.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | other | 10.0 mg/kg/injection | 124.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | other | 20.0 mg/kg/injection | 132.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | other | 40.0 mg/kg/injection | 155.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | other | 40.0 mg/kg/injection | 178.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | other | 80.0 mg/kg/injection | 148.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | other | 160.0 mg/kg/injection | 145.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | other | 320.0 mg/kg/injection | 143.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | other | 320.0 mg/kg/injection | 160.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | other | 640.0 mg/kg/injection | 91.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | other | 1280.0 mg/kg/injection | 0.0 | Experiment continued until the death of all animals; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | alkali diluted with saline | 7.0 mg/kg/injection | 116.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | alkali diluted with saline | 14.0 mg/kg/injection | 134.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | alkali diluted with saline | 28.0 mg/kg/injection | 166.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (oral) | mean survival time | alkali diluted with saline | 56.0 mg/kg/injection | 171.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (im) | mean survival time | other | 10.0 mg/kg/injection | 118.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (im) | mean survival time | other | 20.0 mg/kg/injection | 121.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (im) | mean survival time | other | 40.0 mg/kg/injection | 143.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (im) | mean survival time | other | 80.0 mg/kg/injection | 126.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (im) | mean survival time | other | 80.0 mg/kg/injection | 150.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (im) | mean survival time | other | 160.0 mg/kg/injection | 102.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX Z (im) | mean survival time | other | 320.0 mg/kg/injection | 0.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX008 (ip) | mean survival time | alkali diluted with saline | 20.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX008 (ip) | mean survival time | alkali diluted with saline | 30.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX008 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX008 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX008 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX008 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX008 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX008 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX008 (ip) | mean survival time | alkali diluted with saline | 200.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX008 (ip) | mean survival time | alkali diluted with saline | 300.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 13.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.5 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.5 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.5 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 14.5 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 15.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 15.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 15.0 mg/kg/injection | 197.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 15.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 16.2 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 16.34 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 21.9 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 21.9 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 21.9 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 21.9 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 21.9 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 22.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 22.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 22.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 22.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 22.0 mg/kg/injection | 184.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 22.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 22.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 22.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 22.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 22.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 25.4 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 25.46 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 33.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 33.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 33.0 mg/kg/injection | 193.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 33.0 mg/kg/injection | 208.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 33.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 33.0 mg/kg/injection | 192.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 33.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 33.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 33.0 mg/kg/injection | 210.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 33.0 mg/kg/injection | 201.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 34.17 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 34.17 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 34.17 mg/kg/injection | 209.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 34.17 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 34.17 mg/kg/injection | 210.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 38.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 38.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 49.5 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 49.5 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 49.5 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 49.5 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 49.5 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 50.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 50.0 mg/kg/injection | 196.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 50.0 mg/kg/injection | 196.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 50.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 51.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 51.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 51.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 51.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 51.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 51.0 mg/kg/injection | 197.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 57.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 57.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 74.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 74.25 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 74.25 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 74.25 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 74.25 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 74.25 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 75.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 75.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 75.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 75.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 76.5 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 76.5 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 76.5 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 76.5 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 76.5 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 85.5 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 85.6 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 112.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 114.75 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 114.75 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 114.75 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 114.75 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 114.75 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 129.2 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | carboxymethylcellulose (CMC) | 129.2 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 5; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 10.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 10.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 15.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 15.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 15.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 22.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 22.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 22.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 22.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 33.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 33.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 33.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 33.5 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 50.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 50.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 50.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 5; 04/05 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 50.0 mg/kg/injection | 182.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 75.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 75.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 75.0 mg/kg/injection | 124.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 75.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 112.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 5; 05/05 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | other | 112.5 mg/kg/injection | 84.0 | Antitumor endpoint evaluated on day 5; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | alkali diluted with saline | 16.2 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | alkali diluted with saline | 25.4 mg/kg/injection | 124.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | alkali diluted with saline | 38.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | alkali diluted with saline | 57.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | alkali diluted with saline | 85.6 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q02DX010 (ip) | mean survival time | alkali diluted with saline | 139.2 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03DX Z (ip) | mean survival time | other | 1.9 mg/kg/injection | 123.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q03DX Z (ip) | mean survival time | other | 3.8 mg/kg/injection | 108.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q03DX Z (ip) | mean survival time | other | 7.5 mg/kg/injection | 111.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q03DX Z (ip) | mean survival time | other | 15.0 mg/kg/injection | 116.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q03DX Z (ip) | mean survival time | other | 30.0 mg/kg/injection | 203.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q03DX Z (ip) | mean survival time | other | 30.0 mg/kg/injection | 148.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q03DX Z (ip) | mean survival time | other | 60.0 mg/kg/injection | 154.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q03DX Z (ip) | mean survival time | other | 120.0 mg/kg/injection | 175.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q03DX Z (ip) | mean survival time | other | 240.0 mg/kg/injection | 101.0 | Experiment continued until the death of all animals; 05/05 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 8.0 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 8.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 16.0 mg/kg/injection | 102.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 16.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 32.0 mg/kg/injection | 102.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 32.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 64.0 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 64.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 64.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 64.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 128.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 128.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 128.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 128.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 255.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 01/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 255.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 255.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 255.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 510.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | mean survival time | alkali diluted with saline | 510.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 8.3 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 12.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 19.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 29.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 90.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 180.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 270.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 125.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 250.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | Klucel (hydroxypropylcellulose) (HPC) | 500.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline with Tween-80 | 100.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline with Tween-80 | 101.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline with Tween-80 | 133.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline with Tween-80 | 200.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline with Tween-80 | 202.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline with Tween-80 | 202.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline with Tween-80 | 303.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline with Tween-80 | 400.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline with Tween-80 | 405.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX004 (ip) | mean survival time | alkali diluted with saline | 180.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX004 (ip) | mean survival time | alkali diluted with saline | 240.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX004 (ip) | mean survival time | alkali diluted with saline | 360.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q07DX Z (ip) | mean survival time | other | 4.4 mg/kg/injection | 131.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q07DX Z (ip) | mean survival time | other | 8.8 mg/kg/injection | 146.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q07DX Z (ip) | mean survival time | other | 17.5 mg/kg/injection | 162.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q07DX Z (ip) | mean survival time | other | 35.0 mg/kg/injection | 180.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q07DX Z (ip) | mean survival time | other | 70.0 mg/kg/injection | 153.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q07DX Z (ip) | mean survival time | other | 70.0 mg/kg/injection | 181.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q07DX Z (ip) | mean survival time | other | 140.0 mg/kg/injection | 156.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q07DX Z (ip) | mean survival time | other | 280.0 mg/kg/injection | 156.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q07DX Z (ip) | mean survival time | other | 560.0 mg/kg/injection | 132.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q07DX Z (ip) | mean survival time | other | 560.0 mg/kg/injection | 116.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q07DX Z (ip) | mean survival time | other | 1020.0 mg/kg/injection | 93.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q08DX002 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q08DX002 (ip) | mean survival time | saline | 90.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q08DX002 (ip) | mean survival time | saline | 180.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q08DX002 (ip) | mean survival time | saline | 270.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q08DX002 (ip) | mean survival time | saline | 360.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X001 (ip) | mean survival time | alkali diluted with saline | 109.0 mg/kg/injection | 111.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X001 (ip) | mean survival time | alkali diluted with saline | 146.0 mg/kg/injection | 115.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X004 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X004 (ip) | mean survival time | alkali diluted with saline | 134.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X004 (ip) | mean survival time | alkali diluted with saline | 200.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X004 (ip) | mean survival time | alkali diluted with saline | 300.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X004 (ip) | mean survival time | alkali diluted with saline | 450.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 46; 04/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X009 (ip) | mean survival time | alkali diluted with saline | 18.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q## X009 (ip) | mean survival time | alkali diluted with saline | 27.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q## X009 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q## X009 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q## X009 (ip) | mean survival time | alkali diluted with saline | 90.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q## X009 (ip) | mean survival time | alkali diluted with saline | 135.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q## X009 (ip) | mean survival time | alkali diluted with saline | 200.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q## X015 (ip) | mean survival time | other | 60.0 mg/kg/injection | 107.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X015 (ip) | mean survival time | other | 180.0 mg/kg/injection | 87.0 | Experiment continued until the death of all animals; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X015 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X015 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X015 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X027 (ip) | mean survival time | saline | 7.5 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X027 (ip) | mean survival time | saline | 15.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X027 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X027 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X027 (ip) | mean survival time | saline | 90.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 35; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 16.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 26.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 64.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 64.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 96.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 96.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 100.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 144.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 200.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 216.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 320.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 400.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 46; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 600.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 46; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q## X032 (ip) | mean survival time | alkali diluted with saline | 800.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 46; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q#A X Z (ip) | mean survival time | other | 0.6 mg/kg/injection | 140.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q#A X Z (ip) | mean survival time | other | 1.25 mg/kg/injection | 148.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q#A X Z (ip) | mean survival time | other | 2.5 mg/kg/injection | 162.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q#A X Z (ip) | mean survival time | other | 5.0 mg/kg/injection | 147.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q#A X Z (ip) | mean survival time | other | 5.0 mg/kg/injection | 145.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q#A X Z (ip) | mean survival time | other | 10.0 mg/kg/injection | 149.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q#A X Z (ip) | mean survival time | other | 20.0 mg/kg/injection | 153.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q#A X Z (ip) | mean survival time | other | 40.0 mg/kg/injection | 94.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q#B X015 (ip) | mean survival time | saline | 30.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q#B X015 (ip) | mean survival time | saline | 60.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |